<DOC>
	<DOCNO>NCT01106430</DOCNO>
	<brief_summary>This study evaluate long take ADHD symptom improve subject judge Investigator inadequate response methylphenidate therapy . The study also test safety Lisdexamfetamine Dimesylate well work .</brief_summary>
	<brief_title>Comparison Lisdexamfetamine Dimesylate With Atomoxetine HCl Attention-Deficit/Hyperactivity Disorder ( ADHD ) Subjects With Inadequate Response Methylphenidate</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Subject historical current inadequate response methylphenidate ( MPH ) treatment . Inadequate response include limited presence residual symptom , associate impairment inadequate duration action and/or variability symptom control , and/or Investigator feel subject may derive benefit alternative drug treatment MPH therapy . Subject male female age 617 year inclusive time consent Subject must meet Diagnostic Statistical Manual Mental Disorders , fourth edition . Text Revision ( DSM IV TR ) criteria primary diagnosis ADHD base detailed psychiatric evaluation Subject must baseline ADHDRSIV total score 28 . Subject take 1 MPH treatment ( example , 2 different MPH treatment ) . Examples include limited RITALIN immediate release ( IR ) EQUASYM IR ; MEDIKINET IR CONCERTA ; RITALIN longacting LA CONCERTA . Note : include subject take IR MPH dose titration shortterm basis ( example , Â£4 week ) adequate response In Investigator 's judgement , subject fail respond 1 previous course ( ) MPH treatment . Failure respond include worsen symptom change/minimal improvement symptom . Subject previously expose STRATTERA amphetamine therapy Subject previously demonstrate intolerable side effect 1 MPH treatment limited titration acceptable efficacy require decrease dose result unacceptable tolerability and/or efficacy Subject current , control ( require restrict medication ) uncontrolled , comorbid psychiatric diagnosis significant symptom severe comorbid Axis II disorder severe Axis I disorder symptomatic manifestation , agitate state , mark anxiety , tension , opinion examine physician , contraindicate treatment SPD489 STRATTERA confound efficacy safety assessment . Subject conduct disorder . Oppositional Defiant Disorder exclusionary .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>ADHD</keyword>
</DOC>